Researchers investigated the potential association between cutaneous lymphoma and anti-TNFα therapy in a recent study.

FDA Alerts

FDA Alerts
Saturday, January 16, 2016
The FDA recently approved secukinumab (Cosentyx) for 2 new indications for the treatment of adult patients with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA).

News

News
Friday, September 1, 2017
Recent research investigated the growing worry that drugs used to treat plaque psoriasis may also cause inflammatory bowel disease in patients.
News
Friday, August 11, 2017
The costliest patients with psoriasis have significantly higher prevalence of comorbidities, prescription fills, inpatient, and emergency utilization, but not biologic medication use or biologic costs, according to the results of a recent study.
News
Thursday, August 3, 2017
The National Psoriasis Foundation (NPF) has transformed August from Psoriasis Awareness Month to Psoriasis Action Month, with the mission of helping people with psoriasis set goals and take control.
News
Saturday, July 29, 2017
A support program designed to assist patients with psoriasis and other autoimmune diseases was associated with greater medication adherence, improved persistence, and reduced all-cause and disease-related medical and total health care costs, according to the results of a recent study

NPF Endorsed Articles

NPF Endorsed Articles
Monday, December 15, 2014
Test Your Psoriasis Knowledge 1. A 66-year-old woman’s psoriasis suddenly worsened after she underwent a biopsy of a tumor in her breast.
NPF Endorsed Articles
Thursday, October 23, 2014
Thirteen early-career physicians receive National Psoriasis Foundation fellowships to study psoriasis.  
NPF Endorsed Articles
Friday, September 19, 2014
This article, based on a presentation that was given at the Interdisciplinary Autoimmune Summit held in June 2014 in Las Vegas, describes how to select the right biologic for a patient who has not previously received biologic therapy.   
NPF Endorsed Articles
Thursday, August 21, 2014
The interleukin-17A inhibitor secukinumab was effective in the treatment of psoriasis, according to 2 large studies. 

Research in Review

Research in Review
Monday, July 25, 2016
Getting patients to take medication as prescribed is essential to getting optimal clinical responses.
Research in Review
Monday, June 20, 2016
Inverse psoriasis is a variant of psoriasis that affects only the intertriginous areas such as the inguinal fold, gluteal cleft, and axillae.
Research in Review
Thursday, June 16, 2016
Research shows that psoriasis is much more than a skin condition.
Research in Review
Monday, June 6, 2016
The Renbök phenomenon is uncommon and describes how the presence of one dermatologic disorder inhibits the effect of another preexisting dermatologic pathology in the same patient.